Cargando…

The how’s and what’s of vaccine reactogenicity

Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or headache. The experience of symptoms following vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hervé, Caroline, Laupèze, Béatrice, Del Giudice, Giuseppe, Didierlaurent, Arnaud M., Tavares Da Silva, Fernanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760227/
https://www.ncbi.nlm.nih.gov/pubmed/31583123
http://dx.doi.org/10.1038/s41541-019-0132-6
_version_ 1783453836580487168
author Hervé, Caroline
Laupèze, Béatrice
Del Giudice, Giuseppe
Didierlaurent, Arnaud M.
Tavares Da Silva, Fernanda
author_facet Hervé, Caroline
Laupèze, Béatrice
Del Giudice, Giuseppe
Didierlaurent, Arnaud M.
Tavares Da Silva, Fernanda
author_sort Hervé, Caroline
collection PubMed
description Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or headache. The experience of symptoms following vaccination can lead to needle fear, long-term negative attitudes and non-compliant behaviours, which undermine the public health impact of vaccination. This review presents current knowledge on the potential causes of reactogenicity, and how host characteristics, vaccine administration and composition factors can influence the development and perception of reactogenicity. The intent is to provide an overview of reactogenicity after vaccination to help the vaccine community, including healthcare professionals, in maintaining confidence in vaccines by promoting vaccination, setting expectations for vaccinees about what might occur after vaccination and reducing anxiety by managing the vaccination setting.
format Online
Article
Text
id pubmed-6760227
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67602272019-10-03 The how’s and what’s of vaccine reactogenicity Hervé, Caroline Laupèze, Béatrice Del Giudice, Giuseppe Didierlaurent, Arnaud M. Tavares Da Silva, Fernanda NPJ Vaccines Review Article Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site pain, redness, swelling or induration at the injection site, as well as systemic symptoms, such as fever, myalgia, or headache. The experience of symptoms following vaccination can lead to needle fear, long-term negative attitudes and non-compliant behaviours, which undermine the public health impact of vaccination. This review presents current knowledge on the potential causes of reactogenicity, and how host characteristics, vaccine administration and composition factors can influence the development and perception of reactogenicity. The intent is to provide an overview of reactogenicity after vaccination to help the vaccine community, including healthcare professionals, in maintaining confidence in vaccines by promoting vaccination, setting expectations for vaccinees about what might occur after vaccination and reducing anxiety by managing the vaccination setting. Nature Publishing Group UK 2019-09-24 /pmc/articles/PMC6760227/ /pubmed/31583123 http://dx.doi.org/10.1038/s41541-019-0132-6 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review Article
Hervé, Caroline
Laupèze, Béatrice
Del Giudice, Giuseppe
Didierlaurent, Arnaud M.
Tavares Da Silva, Fernanda
The how’s and what’s of vaccine reactogenicity
title The how’s and what’s of vaccine reactogenicity
title_full The how’s and what’s of vaccine reactogenicity
title_fullStr The how’s and what’s of vaccine reactogenicity
title_full_unstemmed The how’s and what’s of vaccine reactogenicity
title_short The how’s and what’s of vaccine reactogenicity
title_sort how’s and what’s of vaccine reactogenicity
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760227/
https://www.ncbi.nlm.nih.gov/pubmed/31583123
http://dx.doi.org/10.1038/s41541-019-0132-6
work_keys_str_mv AT hervecaroline thehowsandwhatsofvaccinereactogenicity
AT laupezebeatrice thehowsandwhatsofvaccinereactogenicity
AT delgiudicegiuseppe thehowsandwhatsofvaccinereactogenicity
AT didierlaurentarnaudm thehowsandwhatsofvaccinereactogenicity
AT tavaresdasilvafernanda thehowsandwhatsofvaccinereactogenicity
AT hervecaroline howsandwhatsofvaccinereactogenicity
AT laupezebeatrice howsandwhatsofvaccinereactogenicity
AT delgiudicegiuseppe howsandwhatsofvaccinereactogenicity
AT didierlaurentarnaudm howsandwhatsofvaccinereactogenicity
AT tavaresdasilvafernanda howsandwhatsofvaccinereactogenicity